Use of decentralized approach in a Phase 1 pharmacokinetic trial shows the ability to enable remote data collection and monitoring, which could improve patient access and enhance the efficiency of ...

According to the Sacnilk report, the movie grossed an estimated Rs 0.07 crore on Day 8 (approx) in the India net collection. The movie’s overall performance, however, remains remarkable. In the first ...

Sankranthiki Vasthunam Box Office Prediction Day 8: Venkatesh-starrer Sankranthi's release, a family comedy-caper titled Sankranthiki Vasthunam, is racing towards new milestones at the box office ...

The box office collection remained decent on the second Sunday. Scroll below for the latest update on day 8. Vishal starrer was delayed for as long as 12 years due to production and financial issues.

Daaku Maharaaj Box Office Collection Day 8 Early Updates: Daaku Maharaaj has been making headlines and already surpassed the expectations in terms of numbers ever since it was released.

Here's how much the film has minted on day 8 at the box office ... However, Sacnilk revealed that the combined overseas collection amounted to just Rs 30 crore by day 7. Unfortunately, despite ...

Game Changer box office collection day 8: Game Changer couldn’t change the game for Ram Charan, despite featuring him in his first full-fledged lead role since RRR. Game Changer was released on ...

Game Changer Box Office Collection Day 8: Ram Charan starrer hit the big screen on January 10.(Sumit Kadel @X) Game Changer Box Office Day 8: Ram Charan starrer movie witnessed another drop in its ...

Game Changer Box Office Collection Day 8: Ram Charan starrer witnessed cold response even after the hype it created before its release due to several underlying reasons. The political drama slowed ...

Ram Charan and Kiara Advani-starrer Game Changer has experienced another dip in its box office collection. Despite witnessing a slight ... With this, the film’s total domestic earnings now stand at Rs ...

They also offer V-8s paired with four-speed automatics, but no one—BluePrint or anyone else for that matter—sells a V-8/eight-speed automatic transmission drop-in package in the aftermarket. That void ...

Neumora Therapeutics’ phase 3 fail was worse than analysts feared. The biotech provided a closer look at the data Tuesday, shutting down one source of hope analysts had clung to after the ...